Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies

@inproceedings{Chen2016IntraArterialCA,
  title={Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies},
  author={M Chen and Junyang Zhao and Jiejun Xia and Zhenyin Liu and Hua Jiang and G. L. Shen and Haibo Li and Yizhou Jiang and Jing Zhang},
  booktitle={PloS one},
  year={2016}
}
PURPOSE Retinoblastoma is the most common primary malignant intra-ocular tumor in children. Although intra-arterial chemotherapy (IAC) by selectively infusing chemotherapy through the ophthalmic artery has become an essential technique in the treatment of advanced intra-ocular retinoblastoma in children, the outcome of IAC as primary therapy for infants less than 3 months of age remains unknown. In this retrospective study, we reviewed the outcome of IAC as primary therapy for retinoblastoma in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial

  • AJ Davidson, N Disma, JC de Graaff, DE Withington, L Dorris, G Bell
  • Lancet
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…